Scandinavian ChemoTech
1,25
SEK
+13,64 %
Mindre end 1K følgere
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+13,64%
+12,61%
-30,17%
-11,97%
-44,2%
-42,44%
-90,35%
-76,96%
-96,68%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Læs mereMarkedsværdi
29,18 mio. SEK
Aktieomsætning
8,02 t SEK
Omsætning
6,57 mio.
EBIT %
-194,82 %
P/E
-
Udbytteafkast, %
-
Finanskalender
6.5
2025
Delårsrapport Q1'25
13.5
2025
Generalforsamling '25
12.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024
Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools